MITRAL VALVE REGURGITATION INDUCES STRUCTURAL CHANGES
二尖瓣反流引起结构变化
基本信息
- 批准号:2399123
- 负责人:
- 金额:$ 35.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-07-15 至 1998-06-30
- 项目状态:已结题
- 来源:
- 关键词:biomechanics clinical research collagen computer assisted patient care computer simulation disease /disorder model elastin heart function histopathology human subject immunocytochemistry light microscopy mechanical stress mitral valve mitral valve insufficiency morphology mucopolysaccharides myocardial ischemia /hypoxia procollagen protein biosynthesis scars sheep structural biology tissue /cell preparation
项目摘要
DESCRIPTION: (Adapted from investigator's abstract) The broad long term
objectives of this research are to use a unique 3-D computer model to
improve the timing and type of treatment offered to patients with mitral
valve regurgitation, and to assess whether there is a role for earlier valve
repair in selected etiologies. As the valve is affected by disease, the
functional anatomy is often altered, the valve becomes regurgitant, and the
normal distribution of mechanical stresses is disrupted. It is the central
hypothesis of this application that mitral valve regurgitation, itself,
induces structural changes and alters mechanical function. The clinical
implication of this hypothesis is that the longer a valve is regurgitant,
the more disrupted will be the tissue and the less likely that a surgical
repair would be successful. The applicants proposed to test several aspects
of this theory and will delineate the mechanisms that contribute to this
process, in a three part approach. In Part One, they proposed to assess
whether regurgitation induces structural change. Experimental sheep models
will be used in which mitral regurgitation is created either by papillary
muscle ischemia, or by disruption of the chordae tendineae. After 4, 8, or
16 weeks of regurgitation, the valves will be evaluated for the amount of
and the distribution of collagen, as well as changes in elastin and
glycosaminoglycans (GAGs). This will answer: 1) Is there an increase in
collagen synthesis and/or a change in collagen types in experimentally
created mitral regurgitation? 2) Is there a difference in collagen
synthesis, collagen types or collagen distribution due to the mechanism of
regurgitation? and 3) Is there a concurrent increase in the other
structural components of the valve (elastin and glycosaminoglycans (GAGs))
due to regurgitation. In Part Two, the applicants proposed to assess
whether the structural change is accompanied by changes in the mechanical
properties of mitral valve tissue. The sheep model will be repeated, and in
addition human valves will be obtained from explanted hearts from transplant
recipients. The biaxial mechanical properties of both will be determined,
as well as the collagen orientation to answer: 4) How do the
microstructural changes alter the mechanical properties of the valve tissue?
5) Do the pathologic changes seen in human valves parallel either of the
experimental models? Finally, in Part Three, the applicants proposed to
determine the effect of structural and mechanical property changes on valve
function. A three dimensional finite element model will be used which will
incorporate the data obtained in Parts One and Two, to answer: (6) Do the
microstructural and mechanical property changes significantly alter valve
function as tested in a finite element computer model of the mitral valve?
7) Should clinical management of mitral valve disease be altered?
描述:(改编自调查人员摘要)广泛的长期
本研究的目标是使用一种独特的3-D计算机模型来
改善二尖瓣病变患者的治疗时机和类型
瓣膜返流,并评估早期瓣膜是否起作用
修复选定的病因。由于瓣膜受到疾病的影响,
功能解剖经常改变,瓣膜变得反流,
机械应力的正态分布被打乱。它是中央
这一应用的假说是二尖瓣返流本身,
导致结构变化并改变机械功能。临床部
这一假设的含义是瓣膜返流的时间越长,
组织受到的破坏越大,手术越不可能
修复将是成功的。申请者提出了几个方面的测试
并将描绘出促成这一理论的机制
流程,采用三部分方法。在第一部分,他们建议评估
反流是否会导致结构变化。实验用绵羊模型
将用于二尖瓣关闭不全是由乳头状肌
肌肉缺血,或肌腱索断裂。在4、8或
16周的返流,将评估瓣膜的量
以及胶原的分布,以及弹性蛋白和
糖胺聚糖(GAG)。这个问题的答案是:1)……
实验性的胶原合成和/或胶原类型的改变
造成二尖瓣返流?2)胶原蛋白有区别吗?
合成,胶原类型或胶原分布,由于机制
反胃?3)另一项指标是否同时增加
瓣膜的结构成分(弹性蛋白和糖胺多聚糖(GAG))
由于反胃。在第二部分,申请者建议评估
结构变化是否伴随着机械结构的变化
二尖瓣组织的特性。绵羊模型将重复,并在
额外的人体瓣膜将从移植后的移植心脏中获得
收件人。这两种材料的双轴机械性能将被确定,
以及胶原蛋白的取向回答:4)怎么做的
微结构变化会改变瓣膜组织的机械性能吗?
5)人体瓣膜的病理变化是否平行于
实验模型?最后,在第三部分中,申请者建议
确定结构和机械性能变化对阀门的影响
功能。将使用三维有限元模型,它将
结合在第一部分和第二部分中获得的数据,回答:(6)做
瓣膜的显微组织和力学性能发生显著变化
在二尖瓣的有限元计算机模型中测试的功能?
7)二尖瓣病变的临床处理应该改变吗?
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD P COCHRAN其他文献
RICHARD P COCHRAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD P COCHRAN', 18)}}的其他基金
MITRAL VALVE REGURGITATION INDUCES STRUCTURAL CHANGES
二尖瓣反流引起结构变化
- 批准号:
2910636 - 财政年份:1997
- 资助金额:
$ 35.72万 - 项目类别:
MITRAL VALVE REGURGITATION INDUCES STRUCTURAL CHANGES
二尖瓣反流引起结构变化
- 批准号:
6030789 - 财政年份:1997
- 资助金额:
$ 35.72万 - 项目类别:
MITRAL VALVE REGURGITATION INDUCES STRUCTURAL CHANGES
二尖瓣反流引起结构变化
- 批准号:
6183809 - 财政年份:1997
- 资助金额:
$ 35.72万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 35.72万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 35.72万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 35.72万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 35.72万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 35.72万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 35.72万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 35.72万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 35.72万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 35.72万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 35.72万 - 项目类别: